Brain

CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results

Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025Company…

1 month ago

Cortechs.ai Highlights Groundbreaking NeuroQuant® ARIA Technology in Anticipation of Growing Market Demand

SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- As the global leader in advanced MRI post-processing solutions, Cortechs.ai is proud to highlight…

1 month ago

Fountain Life Adds Exclusive, Concierge Care Services to its APEX Premium Longevity Membership

LAKE NONA, Fla., Nov. 14, 2024 /PRNewswire/ -- Fountain Life, a longevity, preventative health, advanced diagnostics, and therapeutics company, today…

1 month ago

Unify.Health Partners with CFLPA to Revolutionize Athlete Health Management and Safety

Athlete-controlled platform solves persistent problems around transparent, portable and accessible health data VANCOUVER, BC, Nov. 14, 2024 /CNW/ - Unify.Health, which…

1 month ago

Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,…

1 month ago

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria…

1 month ago

FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment

BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's…

1 month ago

Paul VS Tyson – BHOUT, the first punching bag with a brain, partners with the most significant sports event of the decade

LISBON, Portugal, Nov. 13, 2024 /PRNewswire/ -- The BHOUT Bag, world's first "punching bag with a brain" developed by Portuguese…

1 month ago

Ethics Board Approval Granted for Lexaria’s 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp.…

1 month ago

The Menninger Clinic Offering Nation’s First Rapid Targeted Transcranial Magnetic Stimulation to Treat Depression

Menninger is the only hospital in the U.S. to offer groundbreaking treatment HOUSTON, TX / ACCESSWIRE / November 13, 2024…

1 month ago